Works matching DE "EFALIZUMAB"

Results: 98

Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab.

Published in:

Free Radical Research, 2011, v. 45, n. 5, p. 585, doi. 10.3109/10715762.2011.560150

By:

Pastore, Saveria;
Mariani, Valentina;
Lulli, Daniela;
Gubinelli, Emanuela;
Raskovic, Desanka;
Mariani, Serena;
Stancato, Andrea;
de Luca, Chiara;
Pecorelli, Alessandra;
Valacchi, Giuseppe;
Potapovich, Alla I.;
Kostyuk, Vladimir A.;
Korkina, Liudmila G.

Publication type:

Article

Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis.

Published in:

Australasian Journal of Dermatology, 2013, v. 54, n. 4, p. 259, doi. 10.1111/ajd.12044

By:

Tan, Eugene;
Baker, Christopher;
Foley, Peter

Publication type:

Article

From biologic to biologic to biologic: Lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis.

Published in:

Australasian Journal of Dermatology, 2008, v. 49, n. 3, p. 152, doi. 10.1111/j.1440-0960.2008.00463.x

By:

Yip, Leona;
Harrison, Shannon;
Foley, Peter

Publication type:

Article

11. Psoriasis, Acne, etc.

Published in:: 2005
Publication type:: Abstract

Efalizumab, a reversible T-cell modulator for psoriasis.

Published in:

Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 4, doi. 10.1007/s10227-006-0101-3

By:

Shear, Neil H.;
Langley, Richard G.;
Ho, Vincent

Publication type:

Article

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Published in:

Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 26, doi. 10.1007/s10227-006-0104-0

By:

Papp, Kim A.;
Ho, Vincent;
Langley, Richard;
Lynde, Charles;
Poulin, Yves;
Shear, Neil;
Toole, John;
Zip, Catherine

Publication type:

Article

Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis.

Published in:

Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 1, doi. 10.1007/s10227-006-0100-4

By:

Lynde, Charles

Publication type:

Article

A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence.

Published in:

Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 10, doi. 10.1007/s10227-006-0102-2

By:

Poulin, Yves;
Papp, Kim A.;
Carey, Wayne;
Gulliver, Wayne;
Gupta, Aditya K.

Publication type:

Article

Warfarin May Be First to Apply Pharmacogenetics.

Published in:: OB/GYN Clinical Alert, 2009, p. 1
Publication type:: Article

Clinical Dermatology.

Published in:: Current Medical Literature: Dermatology, 2009, v. 14, n. 3, p. 66
Publication type:: Article

Safety labeling updates & new warnings.

Published in:: Formulary, 2008, v. 43, n. 11, p. 425
Publication type:: Article

Biologic psoriasis treatment options expanding.

Published in:: Formulary, 2007, v. 42, n. 5, p. 316
Publication type:: Article

The good, the bad and the malignant.

Published in:

2018

By:

Egeberg, A.

Publication type:

Editorial

Sequential therapy in plaque psoriasis using the ' Hit and Run ' approach: infliximab followed by efalizumab.

Published in:

International Journal of Dermatology, 2012, v. 51, n. 2, p. 236, doi. 10.1111/j.1365-4632.2010.04488.x

By:

Penz, Séverine;
Pelletier, Fabien;
Riou-Gotta, Marie Odile;
Puzenat, Eve;
Levang, Julien;
Mermet, Isabelle;
Humbert, Philippe;
Aubin, François

Publication type:

Article

Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program.

Published in:

International Journal of Dermatology, 2009, v. 48, n. 12, p. 1376, doi. 10.1111/j.1365-4632.2009.04217.x

By:

Foley, Peter;
Freeman, Michael;
Gebauer, Kurt;
Murrell, Dedee;
Shumack, Stephen;
Tyson, Christopher;
Varigos, George

Publication type:

Article

Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.

Published in:

International Journal of Dermatology, 2007, v. 46, n. 6, p. 637, doi. 10.1111/j.1365-4632.2007.03158.x

By:

Menter, Alan;
Hamilton, Tiffani K.;
Toth, Darryl P.;
Leung, Hoi M.;
Wetherill, Graham;
Hennessey, Brian;
Garovoy, Marvin;
Kwon, Paul;
Pariser, David M.

Publication type:

Article

Efalizumab Tedavisinin Kesilmesinin Psoriasisli Hastalarda Ortaya Çıkardığı Sorunlar.

Published in:

Archives of the Turkish Dermatology & Venerology / Turkderm, 2010, v. 44, n. 1, p. 19

By:

Adışen, Esra;
Tezel, Fulya;
Gürer, Mehmet Ali

Publication type:

Article

Is there truly a risk of lymphoma from biologic therapies?

Published in:

Dermatologic Therapy, 2009, v. 22, n. 5, p. 418, doi. 10.1111/j.1529-8019.2009.01258.x

By:

Dommasch, Erica;
Gelfand, Joel M.

Publication type:

Article

Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report.

Published in:

Dermatologic Therapy, 2009, v. 22, n. 4, p. 386, doi. 10.1111/j.1529-8019.2009.01251.x

By:

PRIGNANO, F.;
ZANIERI, F.;
MILANI, S.;
LOTTI, T.

Publication type:

Article

Long-term efficacy of up to 15 months’ efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.

Published in:

Dermatologic Therapy, 2008, v. 21, p. S6, doi. 10.1111/j.1529-8019.2008.00235.x

By:

Toth, Darryl P.;
Papp, Kim;
Gratton, David

Publication type:

Article

Etanercept provides a more physiological approach in the treatment of psoriasis.

Published in:

Dermatologic Therapy, 2008, v. 21, p. S1, doi. 10.1111/j.1529-8019.2008.00226.x

By:

ALTOMARE, GIANFRANCO;
AYALA, FABIO;
BERARDESCA, ENZO;
CHIMENTI, SERGIO;
GIANNETTI, ALBERTO;
GIROLOMONI, GIAMPIERO;
LOTTI, TORELLO;
MARTINI, PATRIZIA;
PESERICO, ANDREA;
GUERRA, ANTONIO PUGLISI;
VENA, GINO A.

Publication type:

Article

Efalizumab in the treatment of psoriasis: when comorbidity is an issue.

Published in:

Dermatologic Therapy, 2008, v. 21, p. S25, doi. 10.1111/j.1529-8019.2008.00229.x

By:

PRIGNANO, FRANCESCA;
BUGGIANI, GIONATA;
LOTTI, TORELLO

Publication type:

Article

Mycophenolate mofetil.

Published in:

Dermatologic Therapy, 2007, v. 20, n. 4, p. 229, doi. 10.1111/j.1529-8019.2007.00136.x

By:

Zwerner, Jeffrey;
Fiorentino, David

Publication type:

Article

Efalizumab.

Published in:

Dermatologic Therapy, 2007, v. 20, n. 4, p. 265, doi. 10.1111/j.1529-8019.2007.00139.x

By:

Chacko, Manju;
Weinberg, Jeffrey M.

Publication type:

Article

Immunotargeting in the management of psoriasis.

Published in:

ImmunoTargets & Therapy, 2013, v. 2, p. 51, doi. 10.2147/ITT.S32038

By:

Kaffenberger, Benjamin H.;
Kaffenberger, Thomas M.;
Wong, Henry K.

Publication type:

Article

Palmoplantar Pustular Psoriasis: Successful Therapy with Efalizumab after Non-response to Infliximab.

Published in:

2008

By:

Wozel, Gottfried;
Vitéz, Lilla

Publication type:

Case Study

IN THIS ISSUE...

Published in:

Acta Dermato-Venereologica, 2008, v. 88, n. 2, p. 99, doi. 10.2340/00015555-0449

By:

Michaëlson, Gerd

Publication type:

Article

Treatment of Recalcitrant Dermatomyositis with Efalizumab.

Published in:

2006

By:

Huber, Andrea;
Gaffal, Evelyn;
Bieber, Thomas;
Tüting, Thomas;
Wenzel, Joerg

Publication type:

Case Study

Biological therapies and the quality of life issue in psoriasis.

Published in:

Maedica - a Journal of Clinical Medicine, 2008, v. 3, n. 1, p. 40

By:

Solovan, Caius Silviu;
Mihaescu, Virgil Oreste

Publication type:

Article

BIOLOGICAL THERAPY OF PSORIASIS.

Published in:

Indian Journal of Dermatology, 2010, v. 55, n. 2, p. 161, doi. 10.4103/0019-5154.62754

By:

Sivamani, Raja K.;
Correa, Genevieve;
Ono, Yoko;
Bowen, Michael P.;
Raychaudhuri, Siba P.;
Maverakis, Emanual

Publication type:

Article

Efalizumab: suspension of marketing authorization.

Published in:: WHO Drug Information, 2009, v. 23, n. 1, p. 35
Publication type:: Article

Efalizumab: updated labelling.

Published in:: WHO Drug Information, 2008, v. 22, n. 4, p. 292
Publication type:: Article

Efalizumab: Results of a 3-Year Continuous Dosing Study for the Long-Term Control of Psoriasis.

Published in:: Dermatology Nursing, 2008, v. 20, n. 6, p. 487
Publication type:: Article

PII-71.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P54, doi. 10.1016/j.clpt.2005.12.196

By:

Ng, C. M.;
Bauer, R. J.

Publication type:

Article

US FDA warns of serious risks with psoriasis drug Raptiva®.

Published in:: Expert Review of Anti-infective Therapy, 2009, v. 7, n. 4, p. 393
Publication type:: Article

Guillain-Barré syndrome after short-course efalizumab treatment.

Published in:

2010

By:

Turatti, Marco;
Tamburin, Stefano;
Idone, Domenico;
Praitano, Maria;
Zanette, Giampietro

Publication type:

Letter

Prediction of the pharmacokinetics, pharmacodynamics, and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model.

Published in:

Frontiers in Immunology, 2015, v. 5, p. 1, doi. 10.3389/fimmu.2014.00670

By:

Chetty, Manoranjenni;
Linzhong Li;
Rose, Rachel;
Machavaram, Krishna;
Jamei, Masoud;
Rostami-Hodjegan, Amin;
Gardner, Iain;
Frenkel, Dan;
Olive, Daniel

Publication type:

Article

Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial.

Published in:

Drug Safety, 2008, v. 31, n. 8, p. 715, doi. 10.2165/00002018-200831080-00008

By:

Hamilton, Tiffani;
Menter, Alan;
Caro, Ivor;
Compton, Peter;
Sobell, Jeffrey;
Papp, Kim A

Publication type:

Article

Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn's Disease: an open-label pilot study.

Published in:

2011

By:

James, Dustin;
Seo, Da;
Chen, Jiajing;
Vemulapalli, Caroline;
Stone, Christian;
James, Dustin G;
Seo, Da Hea;
Stone, Christian D

Publication type:

journal article

New Developments in the Pharmacogenetics of Psoriasis: HLA-Cw6 as a Marker for the Treatment of Psoriasis with Biological Therapies.

Published in:

Advances in Psoriasis & Inflammatory Skin Diseases, 2010, v. 1, n. 4, p. 125

By:

Costanzo, Antonio;
Spallone, Giulia;
Talamonti, Marina;
Botti, Elisabetta;
Chimenti, Sergio

Publication type:

Article

Treatment Options for Psoriasis Patients Who Have Failed at Least One Biological Therapy.

Published in:

Advances in Psoriasis & Inflammatory Skin Diseases, 2010, v. 1, n. 4, p. 119

By:

Frankel, Amylynne;
Lebwohl, Mark

Publication type:

Article

Efalizumab effective and safe in moderate to severe psoriasis.

Published in:: British Journal of Hospital Medicine (17508460), 2008, v. 69, n. 10, p. 553
Publication type:: Article

Efalizumab appears safe for long-term use in psoriasis patients.

Published in:: Expert Review of Clinical Immunology, 2008, v. 4, n. 4, p. 412
Publication type:: Article

Chemokine Receptors: Attractive Targets for Drug Discovery.

Published in:

Annals of the New York Academy of Sciences, 2005, v. 1051, n. 1, p. 647, doi. 10.1196/annals.1361.109

By:

GODESSART, NURIA

Publication type:

Article

A mathematical analysis of rebound in a target-mediated drug disposition model: II. With feedback.

Published in:

Journal of Mathematical Biology, 2017, v. 75, n. 1, p. 33, doi. 10.1007/s00285-016-1073-6

By:

Aston, Philip;
Derks, Gianne;
Agoram, Balaji;
Graaf, Piet

Publication type:

Article

Off-label use of biologicals in the management of inflammatory oral mucosal disease.

Published in:

Journal of Oral Pathology & Medicine, 2008, v. 37, n. 10, p. 575, doi. 10.1111/j.1600-0714.2008.00693.x

By:

O'Neill, Iain David

Publication type:

Article

Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2015, v. 29, n. 9, p. 1742, doi. 10.1111/jdv.12981

By:

Sator, P.;
Richter, L.;
Saxinger, W.;
Vasiljevic, M.;
Stingl, G.

Publication type:

Article

Sequential treatment with biologics: switching from efalizumab to etanercept in 35 patients with high-need psoriasis Antoniou et al. Switching between biological agents for the treatment of psoriasis.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 12, p. 1413, doi. 10.1111/j.1468-3083.2010.03661.x

By:

Antoniou, C.;
Dessinioti, C.;
Vergou, T.;
Stratigos, A. J.;
Avgerinou, G.;
Kostaki, M.;
Katsambas, A.

Publication type:

Article

Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 7, p. 837, doi. 10.1111/j.1468-3083.2009.03202.x

By:

Ibler, K.;
Dam, T. N.;
Gniadecki, R.;
Kragballe, K.;
Jemec, G. B. E.;
Agner, T.

Publication type:

Article

Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities.

Published in:

Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 5, p. 555, doi. 10.1111/j.1468-3083.2009.03464.x

By:

Prignano, F.;
Pescitelli, L.;
Ricceri, F.;
Lotti, T.

Publication type:

Article